This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

Source: www.marketwatch.com ·
Section: business-tech ·
Bias: Left
· Published: Wed, 23 Sep 2026 21:59:00 GMT
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Read the full article at www.marketwatch.com →
The same story across the political spectrum (4 sources)
← Back to FlashTopics.com